Berlin, Germany

Reinhard Schmitz

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 118(Granted Patents)


Company Filing History:


Years Active: 2001-2018

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Reinhard Schmitz: Innovator in Pharmaceutical Compositions

Introduction

Reinhard Schmitz is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, holding a total of four patents. His work focuses on developing innovative compositions that enhance the efficacy and stability of medications.

Latest Patents

Among his latest patents, Reinhard Schmitz has developed pharmaceutical compositions containing dexketoprofen and tramadol. This patent describes a solid oral dosage form that aims to improve patient outcomes. Additionally, he has created pediatric oral liquid compositions containing nepadutant. These compositions are designed to be stable and suitable for pediatric use in treating gastrointestinal diseases, utilizing PGS as a solubilizer and optionally a chelating agent.

Career Highlights

Throughout his career, Reinhard Schmitz has worked with several prominent companies in the pharmaceutical industry. Notably, he has been associated with Inhale Therapeutic Systems, Inc. and Actipac Biosystems GmbH. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Reinhard has collaborated with several professionals in his field, including Georg Rößling and Celal Albayrak. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

Reinhard Schmitz is a distinguished inventor whose work in pharmaceutical compositions has made a significant impact on the industry. His innovative approaches continue to pave the way for advancements in medication formulations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…